Reviva Pharmaceuticals (RVPH) News Today $0.44 -0.03 (-6.90%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.44 +0.00 (+0.78%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Consensus Recommendation of "Buy" from AnalystsJuly 30, 2025 | americanbankingnews.comReviva Pharmaceuticals Holdings, Inc. (RVPHW) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comReviva Pharmaceuticals Holdings, Inc. (RVPH) - Investing.comJune 29, 2025 | investing.comReviva Dives on Stock OfferingJune 26, 2025 | baystreet.caReviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public OfferingJune 26, 2025 | globenewswire.comReviva Pharmaceuticals stock falls after announcing public offeringJune 25, 2025 | za.investing.comReviva Pharmaceuticals Holdings, Inc. Announces Proposed Public OfferingJune 25, 2025 | globenewswire.comRVPH: Open Label Extension Results & Key Opinion Leader DiscussionJune 5, 2025 | finance.yahoo.comReviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid ConferenceJune 5, 2025 | globenewswire.comReviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in SchizophreniaJune 2, 2025 | globenewswire.comReviva Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 15, 2025 | globenewswire.comReviva to Participate in the A.G.P. Healthcare Company ShowcaseMay 13, 2025 | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Icon (ICLR), Reviva Pharmaceuticals Holdings (RVPH) and SurModics (SRDX)May 4, 2025 | theglobeandmail.comReviva to Participate in the Citizens Life Sciences ConferenceApril 29, 2025 | finance.yahoo.comRVPH: M&A Deals Highlight Brilaroxazine ValueApril 7, 2025 | finance.yahoo.comRoth MKM Reaffirms Their Buy Rating on Reviva Pharmaceuticals Holdings (RVPH)April 5, 2025 | markets.businessinsider.comReviva Reports Full Year 2024 Financial Results and Recent Business HighlightsMarch 31, 2025 | markets.businessinsider.comReviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS CongressMarch 30, 2025 | globenewswire.comUnusually active option classes on open February 12thFebruary 12, 2025 | markets.businessinsider.comReviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Average Recommendation of "Buy" from AnalystsFebruary 5, 2025 | marketbeat.comReviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | globenewswire.comReviva to Participate in the 2025 BIO CEO & Investor ConferenceJanuary 30, 2025 | globenewswire.comShort Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Decreases By 35.9%January 29, 2025 | marketbeat.comHC Wainwright Has Positive Outlook of RVPH FY2024 EarningsJanuary 24, 2025 | marketbeat.comReviva Pharmaceuticals price target lowered to $11 from $14 at H.C. WainwrightJanuary 22, 2025 | markets.businessinsider.comReviva Pharmaceuticals (NASDAQ:RVPH) Given New $11.00 Price Target at HC WainwrightJanuary 22, 2025 | marketbeat.comReviva Pharmaceuticals (NASDAQ:RVPH) Receives Buy Rating from D. Boral CapitalJanuary 22, 2025 | marketbeat.comReviva Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:RVPH)January 22, 2025 | marketbeat.comTraders Buy Large Volume of Call Options on Reviva Pharmaceuticals (NASDAQ:RVPH)January 21, 2025 | marketbeat.comReviva Pharmaceuticals' (RVPH) Buy Rating Reiterated at D. Boral CapitalJanuary 21, 2025 | marketbeat.comShort Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Drops By 35.9%January 14, 2025 | marketbeat.comReviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Consensus Recommendation of "Buy" by AnalystsJanuary 11, 2025 | marketbeat.comReviva Pharmaceuticals (NASDAQ:RVPH) Upgraded by Roth Capital to "Strong-Buy" RatingJanuary 11, 2025 | marketbeat.comReviva Pharmaceuticals upgraded to Buy from Hold at MaximJanuary 10, 2025 | markets.businessinsider.comReviva Pharmaceuticals (NASDAQ:RVPH) Upgraded to Buy at Maxim GroupJanuary 10, 2025 | marketbeat.comReviva Pharmaceuticals (NASDAQ:RVPH) Coverage Initiated by Analysts at Roth MkmJanuary 10, 2025 | marketbeat.comReviva to Participate in the Lytham Partners 2025 Investor Healthcare SummitJanuary 7, 2025 | globenewswire.comReviva Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RVPH)January 2, 2025 | marketbeat.comFY2024 Earnings Forecast for RVPH Issued By Zacks Small CapDecember 25, 2024 | marketbeat.comRVPH: Preliminary OLE ReadoutDecember 23, 2024 | msn.comReviva Pharmaceuticals Strengthens Financial Position with OfferingDecember 18, 2024 | markets.businessinsider.comReviva Pharmaceuticals 12M share Spot Secondary priced at $1.50December 17, 2024 | markets.businessinsider.comReviva Announces Proposed Public OfferingDecember 16, 2024 | globenewswire.comReviva Announces Prel. Topline OLE Data Of Phase 3 RECOVER Study Of Brilaroxazine In SchizophreniaDecember 16, 2024 | markets.businessinsider.comReviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is LowDecember 11, 2024 | seekingalpha.comRVPH: Year-End OLE UpdateNovember 19, 2024 | msn.comReviva Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 14, 2024 | globenewswire.comReviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024November 6, 2024 | globenewswire.comReviva to Participate in the UBS Global Healthcare ConferenceOctober 31, 2024 | globenewswire.comReviva to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 8, 2024 | globenewswire.com Get Reviva Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVPH and its competitors with MarketBeat's FREE daily newsletter. Email Address RVPH Media Mentions By Week RVPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVPH News Sentiment▼-0.500.45▲Average Medical News Sentiment RVPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVPH Articles This Week▼21▲RVPH Articles Average Week Get Reviva Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTGN News ORMP News ARTV News XBIT News ENTX News MIST News CABA News QNCX News EXOZ News EPIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVPH) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVPH Stock Alerts